Published in Int J Radiat Oncol Biol Phys on March 06, 2010
Comparison of electron and x-ray beams for tumor bed boost irradiation in breast-conserving treatment. J Breast Cancer (2013) 0.89
The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registration. Radiat Oncol (2013) 0.78
A clip-based protocol for breast boost radiotherapy provides clear target visualisation and demonstrates significant volume reduction over time. J Med Radiat Sci (2015) 0.77
Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys (2003) 2.56
Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys (2009) 2.27
Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys (2004) 2.17
Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys (2009) 1.96
What do recent studies on lumpectomy cavity volume change imply for breast clinical target volumes? Int J Radiat Oncol Biol Phys (2008) 1.94
Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis. Radiother Oncol (2010) 1.81
Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.75
Automatic delineation of on-line head-and-neck computed tomography images: toward on-line adaptive radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.72
The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys (2002) 1.72
Cone-beam-CT guided radiation therapy: A model for on-line application. Radiother Oncol (2005) 1.66
Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg (2007) 1.61
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.58
Evaluation of a 2D diode array for IMRT quality assurance. Radiother Oncol (2004) 1.55
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys (2003) 1.52
Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys (2007) 1.43
Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys (2004) 1.41
Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys (2005) 1.37
Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.35
The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.31
Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys (2002) 1.30
Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys (2011) 1.27
Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.27
The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. Brachytherapy (2013) 1.23
Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys (2008) 1.23
Clinical applications of volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys (2010) 1.23
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg (2005) 1.20
A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol (2012) 1.19
Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol (2011) 1.19
Changes in the respiratory pattern during radiotherapy for cancer in the lung. Radiother Oncol (2006) 1.19
Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys (2004) 1.18
Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. Int J Radiat Oncol Biol Phys (2007) 1.17
Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2009) 1.14
Computed tomography guided management of interfractional patient variation. Semin Radiat Oncol (2005) 1.12
Geometric and dosimetric evaluations of an online image-guidance strategy for 3D-CRT of prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.11
Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer? J Thorac Oncol (2012) 1.11
Application of dose compensation in image-guided radiotherapy of prostate cancer. Phys Med Biol (2006) 1.10
Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance. Int J Radiat Oncol Biol Phys (2010) 1.09
Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group. Int J Radiat Oncol Biol Phys (2012) 1.06
Adaptive radiotherapy: merging principle into clinical practice. Semin Radiat Oncol (2010) 1.06
On-line target position localization in the presence of respiration: a comparison of two methods. Int J Radiat Oncol Biol Phys (2007) 1.05
The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2004) 1.05
Population and patient-specific target margins for 4D adaptive radiotherapy to account for intra- and inter-fraction variation in lung tumour position. Phys Med Biol (2006) 1.04
Three-dimensional evaluation of intra- and interfraction immobilization of lung and chest wall using active breathing control: a reproducibility study with breast cancer patients. Int J Radiat Oncol Biol Phys (2003) 1.04
Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial. Ann Surg Oncol (2013) 1.03
Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension? Int J Radiat Oncol Biol Phys (2006) 1.03
Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.03
Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity. Int J Radiat Oncol Biol Phys (2007) 1.03
Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol (2002) 1.02
The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2008) 1.02
Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. Int J Radiat Oncol Biol Phys (2008) 1.01
Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg (2006) 0.99
Planning study comparison of real-time target tracking and four-dimensional inverse planning for managing patient respiratory motion. Int J Radiat Oncol Biol Phys (2008) 0.98
Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 0.97
Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys (2011) 0.97
Cumulative lung dose for several motion management strategies as a function of pretreatment patient parameters. Int J Radiat Oncol Biol Phys (2009) 0.96
A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Int J Radiat Oncol Biol Phys (2005) 0.96
Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Clin Breast Cancer (2012) 0.95
Adaptive radiation therapy for prostate cancer. Semin Radiat Oncol (2010) 0.95
The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys (2002) 0.94
The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. Cancer Radiother (2004) 0.94
Study of robustness of IMPT and IMRT for prostate cancer against organ movement. Int J Radiat Oncol Biol Phys (2009) 0.94
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation. Cancer (2012) 0.94
Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model. Int J Radiat Oncol Biol Phys (2009) 0.93
Intrafraction variation of mean tumor position during image-guided hypofractionated stereotactic body radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.93
Comparison of IGRT registration strategies for optimal coverage of primary lung tumors and involved nodes based on multiple four-dimensional CT scans obtained throughout the radiotherapy course. Int J Radiat Oncol Biol Phys (2011) 0.93
A simplified method of four-dimensional dose accumulation using the mean patient density representation. Med Phys (2008) 0.92
Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling. Magn Reson Imaging (2011) 0.91
Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol (2009) 0.91
Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. Int J Radiat Oncol Biol Phys (2011) 0.91
Real-time catheter tracking for high-dose-rate prostate brachytherapy using an electromagnetic 3D-guidance device: a preliminary performance study. Med Phys (2013) 0.91
Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer. Am J Clin Oncol (2013) 0.91
Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol (2009) 0.90
Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys (2010) 0.90
Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys (2012) 0.90
Differences in effective target volume between various techniques of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys (2010) 0.89
Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation. Breast Cancer Res Treat (2013) 0.89
A model to simulate day-to-day variations in rectum shape. Int J Radiat Oncol Biol Phys (2002) 0.89
Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol (2003) 0.88
Quantitative evaluation of cone-beam computed tomography in target volume definition for offline image-guided radiation therapy of prostate cancer. Radiother Oncol (2009) 0.88
Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors. Radiother Oncol (2011) 0.88
Continuous arc rotation of the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning analysis. Int J Radiat Oncol Biol Phys (2010) 0.87
Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGIT. Ann Surg Oncol (2014) 0.87
MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys (2005) 0.87
Comparison of various online IGRT strategies: The benefits of online treatment plan re-optimization. Radiother Oncol (2008) 0.86
A cost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery. Breast J (2013) 0.86
Comparison of planned versus actual dose delivered for external beam accelerated partial breast irradiation using cone-beam CT and deformable registration. Int J Radiat Oncol Biol Phys (2010) 0.85
Image guidance in external beam accelerated partial breast irradiation: comparison of surrogates for the lumpectomy cavity. Int J Radiat Oncol Biol Phys (2007) 0.85
Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation. Am J Clin Oncol (2010) 0.85
Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys (2005) 0.84
On-line localization of the lumpectomy cavity using surgical clips. Int J Radiat Oncol Biol Phys (2007) 0.84